Received Feb 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ADEN_4_7 | ADENOVIRUS TYPES 4 & 7, LIVE, ORAL (NO BRAND NAME) | TEVA PHARMACEUTICALS | 3 | MH1445 | IM / LG |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z013023 | SC / LG |
Erythema, induration at injection site within 5 days of vaccine given. Papule at thigh. Patient has improved, rash resolving. No associated fever, vomiting, hives, or trouble breathing.
None
None
None